pharmacokinetics of glp 1 receptor agonists Evaluation the of GLP-1 agonist delivered through the BioJet™ oral biotherapeutic delivery platform in a porcine model: an update Pharmacokinetics of Lixisenatide, a GLP-1
Description
International Online Medical Council journals provide an efficacious channel for researchers, students, and faculty members to publish works while maintaining excellence in medical research.
GLP-1 agonists are regularly prescribed by doctors for patients with Type 2 Diabetes. And now theyre the next big thing in the weight loss world.
Its predominant action is on the postprandial glucose levels, with extraglycemic effects on fat metabolism and endovascular function
In conjunction with all the effects, GLP-1 RAs have been found to lower weight and aid in weight management.
Introduction The global obesity market is entering a new phase
Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director
